Overview
19p13.12 microdeletion syndrome (Orphanet: 254346) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 19 at band p13.12. This condition falls under the broader category of chromosomal deletions classified as Q93.5 in ICD-10. Because the deletion removes one or more genes in this chromosomal region, affected individuals typically present with a combination of developmental and neurological features. The syndrome is primarily characterized by intellectual disability, developmental delay (particularly speech and language delay), and variable dysmorphic facial features. Behavioral abnormalities, including features overlapping with autism spectrum disorder, have been reported in some patients. Additional clinical findings may include growth abnormalities, feeding difficulties in infancy, and seizures. The severity and range of symptoms can vary depending on the exact size and position of the deletion and which genes are encompassed. As with most microdeletion syndromes, there is no specific curative treatment. Management is supportive and multidisciplinary, focusing on early intervention programs including speech therapy, occupational therapy, physical therapy, and special educational support. Seizures, if present, are managed with standard antiepileptic medications. Regular developmental assessments and monitoring by a team of specialists including neurologists, geneticists, and developmental pediatricians are recommended to optimize outcomes for affected individuals.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 19p13.12 microdeletion syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 19p13.12 microdeletion syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 19p13.12 microdeletion syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 19p13.12 microdeletion syndrome.
Community
No community posts yet. Be the first to share your experience with 19p13.12 microdeletion syndrome.
Start the conversation →Latest news about 19p13.12 microdeletion syndrome
No recent news articles for 19p13.12 microdeletion syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 19p13.12 microdeletion syndrome
What is 19p13.12 microdeletion syndrome?
19p13.12 microdeletion syndrome (Orphanet: 254346) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 19 at band p13.12. This condition falls under the broader category of chromosomal deletions classified as Q93.5 in ICD-10. Because the deletion removes one or more genes in this chromosomal region, affected individuals typically present with a combination of developmental and neurological features. The syndrome is primarily characterized by intellectual disability, developmental delay (particularly speech and language delay), and variable dysmorp
How is 19p13.12 microdeletion syndrome inherited?
19p13.12 microdeletion syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 19p13.12 microdeletion syndrome typically begin?
Typical onset of 19p13.12 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.